132 related articles for article (PubMed ID: 37865602)
41. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
[TBL] [Abstract][Full Text] [Related]
42. Multi-parametric MRI-based machine learning model for prediction of WHO grading in patients with meningiomas.
Zhao Z; Nie C; Zhao L; Xiao D; Zheng J; Zhang H; Yan P; Jiang X; Zhao H
Eur Radiol; 2024 Apr; 34(4):2468-2479. PubMed ID: 37812296
[TBL] [Abstract][Full Text] [Related]
43. Intratumoral and Peritumoral Edema Radiomics Based on Fat-Suppressed T2- Weighted Imaging for Preoperative Prediction of Triple-Negative Breast Cancer.
Sun R; Hu Y; Wang X; Huang Z; Yang Y; Zhang S; Shi F; Chen L; Liu H; Wang X
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38644724
[TBL] [Abstract][Full Text] [Related]
44. Multiparametric MRI-based radiomics nomogram for predicting malignant transformation of sinonasal inverted papilloma.
Xia Z; Lin N; Chen W; Qi M; Sha Y
Clin Radiol; 2024 Mar; 79(3):e408-e416. PubMed ID: 38142140
[TBL] [Abstract][Full Text] [Related]
45. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
[TBL] [Abstract][Full Text] [Related]
46. Multiparametric MRI-based radiomics for the prediction of microvascular invasion in hepatocellular carcinoma.
Jiang T; He S; Yang H; Dong Y; Yu T; Luo Y; Jiang X
Acta Radiol; 2023 Feb; 64(2):456-466. PubMed ID: 35354318
[TBL] [Abstract][Full Text] [Related]
47. Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer.
Zhong S; Wang F; Wang Z; Zhou M; Li C; Yin J
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292247
[TBL] [Abstract][Full Text] [Related]
48. Preoperative prediction of sonic hedgehog and group 4 molecular subtypes of pediatric medulloblastoma based on radiomics of multiparametric MRI combined with clinical parameters.
Wang Y; Wang L; Qin B; Hu X; Xiao W; Tong Z; Li S; Jing Y; Li L; Zhang Y
Front Neurosci; 2023; 17():1157858. PubMed ID: 37113160
[TBL] [Abstract][Full Text] [Related]
49. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
Wang X; Wan Q; Chen H; Li Y; Li X
Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
[TBL] [Abstract][Full Text] [Related]
50. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
[TBL] [Abstract][Full Text] [Related]
51. Radiomics evaluates the EGFR mutation status from the brain metastasis: a multi-center study.
Cao R; Pang Z; Wang X; Du Z; Chen H; Liu J; Yue Z; Wang H; Luo Y; Jiang X
Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35588722
[No Abstract] [Full Text] [Related]
52. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
[TBL] [Abstract][Full Text] [Related]
53. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.
Zhang L; Jiang D; Chen C; Yang X; Lei H; Kang Z; Huang H; Pang J
Br J Radiol; 2022 Mar; 95(1131):20210191. PubMed ID: 34289319
[TBL] [Abstract][Full Text] [Related]
55. Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma.
Luo Y; Zhuang Y; Zhang S; Wang J; Teng S; Zeng H
Acad Radiol; 2024 Apr; 31(4):1629-1642. PubMed ID: 37643930
[TBL] [Abstract][Full Text] [Related]
56. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
[TBL] [Abstract][Full Text] [Related]
57. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
58. Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma.
Liu HF; Wang M; Wang Q; Lu Y; Lu YJ; Sheng Y; Xing F; Zhang JL; Yu SN; Xing W
Insights Imaging; 2024 Mar; 15(1):97. PubMed ID: 38536542
[TBL] [Abstract][Full Text] [Related]
59. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
[TBL] [Abstract][Full Text] [Related]
60. Multiparametric MRI radiomics in prostate cancer for predicting Ki-67 expression and Gleason score: a multicenter retrospective study.
Zhou C; Zhang YF; Guo S; Wang D; Lv HX; Qiao XN; Wang R; Chang DH; Zhao LM; Zhou FH
Discov Oncol; 2023 Jul; 14(1):133. PubMed ID: 37470865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
